Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02677857 | Developing a Healthy Lifestyle in Breast Cancer Survivors | terminated | N/A | 7 | The University of Tennessee, KnoxvilleOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT02708511 | Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer | terminated | Phase 1 | 2 | Sanjiv Sam GambhirOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor |
| terminated |
| Phase 1 |
| 46 |
| AbbVieINDUSTRY |
| 2 |
| Mar 30, 2018 |
| clinicaltrials |
| NCT00504699 | Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients | terminated | N/A | 120 | New York Medical CollegeOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT00692692 | Use of Dermal Matrix in Breast Reconstruction | terminated | N/A | 36 | Vanderbilt UniversityOTHER | 1 | Mar 19, 2018 | clinicaltrials |
| NCT01010854 | Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer(VPA-FEC100) | terminated | Phase 2 | 6 | University of California, San FranciscoOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT00352872 | Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer | terminated | — | 23 | Indiana UniversityOTHER | 1 | Mar 2, 2018 | clinicaltrials |
| NCT02596867 | Neoadjuvant Propanolol in Breast Cancer(NPBC) | terminated | Phase 2 | 2 | Texas Tech University Health Sciences Center, El PasoOTHER | 1 | Mar 1, 2018 | clinicaltrials |
| NCT00722072 | Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy | terminated | Phase 2 | 12 | OHSU Knight Cancer InstituteOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT03202446 | Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer | terminated | Phase 3 | 18 | Eske Corporation S.A.CINDUSTRY | 1 | Feb 23, 2018 | clinicaltrials |
| NCT00004261 | EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | terminated | Phase 1 | — | University Health Network, TorontoOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT01698281 | Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer | terminated | Phase 2 | 7 | AEterna ZentarisINDUSTRY | 2 | Feb 22, 2018 | clinicaltrials |
| NCT01887288 | Capecitabine With Digoxin for Metastatic Breast Cancer | terminated | Phase 2 | 16 | Western Regional Medical CenterOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT02345772 | Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy(Neohttp) | terminated | Phase 1 / Phase 2 | 4 | Western Regional Medical CenterOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT00632541 | A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer | terminated | Phase 2 | 18 | Hoosier Cancer Research NetworkOTHER | 1 | Feb 14, 2018 | clinicaltrials |
| NCT02120417 | A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer | terminated | Phase 2 | 149 | Incyte CorporationINDUSTRY | 6 | Feb 13, 2018 | clinicaltrials |
| NCT01484041 | Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 12 | Georgetown UniversityOTHER | 1 | Feb 9, 2018 | clinicaltrials |
| NCT01937507 | Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer | terminated | Phase 2 | 2 | Western Regional Medical CenterOTHER | 1 | Feb 7, 2018 | clinicaltrials |
| NCT00095862 | Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers | terminated | Phase 1 / Phase 2 | 24 | Wiseman Research Initiatives LLCINDUSTRY | 1 | Feb 5, 2018 | clinicaltrials |
| NCT02257775 | Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer(EVOLUTION) | terminated | — | 5 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 30, 2018 | clinicaltrials |
| NCT01817374 | Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy | terminated | N/A | 6 | University of Alabama at BirminghamOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT00873366 | Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer | terminated | — | 92 | Mayo ClinicOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT01655992 | A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC) | terminated | Phase 3 | 386 | Fudan UniversityOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT01984892 | Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)(Hiltonol) | terminated | Phase 2 | 8 | Nina BhardwajOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02166658 | A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)(CaBaMet) | terminated | Phase 2 | 8 | AIO-Studien-gGmbHOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02348281 | Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients | terminated | Phase 2 | 1 | Fudan UniversityOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT00864175 | Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 68 | Incyte CorporationINDUSTRY | 1 | Jan 18, 2018 | clinicaltrials |
| NCT01929941 | An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies | terminated | Phase 1 | 5 | Incyte CorporationINDUSTRY | 1 | Jan 17, 2018 | clinicaltrials |
| NCT01815346 | Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG | terminated | Phase 1 / Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 12, 2018 | clinicaltrials |
| NCT00470548 | Abraxane and Alimta in Advanced Solid Tumors | terminated | Phase 1 / Phase 2 | 49 | University of California, DavisOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00516269 | Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients | terminated | Phase 3 | 42 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 3, 2018 | clinicaltrials |
| NCT00290654 | Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ | terminated | Phase 2 | 45 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00376805 | Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer | terminated | Phase 2 | 6 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | terminated | Phase 2 | 13 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00602446 | Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant | terminated | Phase 2 | 4 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT01012362 | Study of Pazopanib and Ixabepilone in Patients With Solid Tumors | terminated | Phase 1 | 31 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT01372618 | Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor | terminated | Phase 1 / Phase 2 | 9 | NYU Langone HealthOTHER | 1 | Dec 27, 2017 | clinicaltrials |
| NCT01425294 | Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment | terminated | — | 231 | AstraZenecaINDUSTRY | 1 | Dec 5, 2017 | clinicaltrials |
| NCT00005993 | Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer | terminated | Phase 1 | — | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT01649258 | Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy | terminated | Phase 1 | 29 | University of Southern CaliforniaOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT00622401 | Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12 | terminated | Phase 1 / Phase 2 | 8 | Beth Israel Deaconess Medical CenterOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT01176838 | A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients | terminated | — | 20 | Wake Forest UniversityOTHER | 1 | Nov 7, 2017 | clinicaltrials |
| NCT01050075 | Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel | terminated | N/A | 7 | City of Hope Medical CenterOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02250118 | Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer(BEVAP) | terminated | Phase 1 | 1 | Institut CurieOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT00581529 | Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy | terminated | Phase 2 | 34 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT01187381 | An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer(HERODOT) | terminated | — | 250 | Hoffmann-La RocheINDUSTRY | 1 | Oct 20, 2017 | clinicaltrials |
| NCT01512199 | Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) | terminated | Phase 1 / Phase 2 | 29 | Daiichi SankyoINDUSTRY | 2 | Oct 18, 2017 | clinicaltrials |
| NCT02017496 | Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment(NeoBCT) | terminated | — | 18 | Oslo University HospitalOTHER | 1 | Oct 17, 2017 | clinicaltrials |
| NCT00813878 | Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease | terminated | — | 126 | City of Hope Medical CenterOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT01217489 | Study Into the Use of Electrical Impedance Mammography in the Diagnosis and Characterisation of Breast Disease(Signascan) | terminated | — | 300 | Oxford University Hospitals NHS TrustOTHER | 1 | Oct 12, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Apr 5, 2018source: clinicaltrials